Multiple Myeloma Research Foundation MMRF supports research aimed at the identification and...

Annual Report 2008

Multiple Myeloma Research Foundation

The mission of the MMRF

is to relentlessly pursue

innovative means that

accelerate the development

of next-generation multiple

myeloma treatments to

extend the lives of patients

and lead to a cure.

MissionStatement

The Mu l t i p l e Mye loma Re s ea rch

Foundation (MMRF) was founded in 1998

by identical twin sisters Kathy Giusti

and Karen Andrews following Kathy’s

diagnosis with multiple myeloma.

Since its inception, the MMRF has

remained committed to breaking

down the barriers s lowing medical

research and drug development. It has

raised more than $115 million for multiple myeloma research,

funded more than 90 research institutions, developed a diverse

research portfolio to deliver better treatments to patients faster,

and built a collaborative research model, the Multiple Myeloma

Research Consortium (MMRC), that is transforming the drug

development process from one that produces results in decades to

one that produces results in a few years.

The work of the MMRF contributed to the FDA approval of four

drugs that have helped almost double life expectancy in some

patients. Because of their success in myeloma, these same drugs are

now being explored as potential treatments for more than 20 other

cancers and diseases. Today the MMRF is funding research into 30

compounds and combination approaches that may represent the

next generation of treatments and is supporting the advancement

of high-priority clinical trials of novel compounds and combination

approaches through the MMRC.

A b o u t t h e

MMRF

MMRF Co-Founders Kathy Giusti and Karen Andrews

Dear Friends,

With you by our side, the Multiple Myeloma Research Foundation (MMRF) is

making a real difference in the lives of multiple myeloma patients and their

families. We have reached incredible milestones in 2008 that are helping

patients live longer lives.

Thanks to your support, in 2008 we:

Initiated 7 new trials of novel and combination treatments through the Multiple

Myeloma Research Consortium (MMRC)

Supported more than 30 compounds and approaches in clinical trials and

pre-clinical studies

Made incredible progress in advancing the Multiple Myeloma Genomics

Initiative – bringing us one step closer to the promise of personalized medicine

for multiple myeloma

I know you are just as excited as I am about the progress we are making. But, in an environment

where funding for biomedical research is diminished and the next new treatments for multiple

myeloma are not expected to be available until 2011, we must work more urgently than ever to

rapidly advance our research portfolio and immediately bridge this gap.

Because of your renewed and dedicated support, we are able to maintain our barrier-breaking

momentum and ensure that the next lifesaving treatment will be there when a patient needs it.

Thank you for your commitment and generosity.

Warmest regards,

Kathy Giusti

Founder and Chief Executive Officer

MMRF Annual Report 2008 3

Report from theChief Operating Officer

Dear Friends,

In these uncertain economic times, it is more importantthan ever that your donation is invested wisely and responsibly.As one the most efficient and effective charities worldwide,the Multiple Myeloma Research Foundation (MMRF) iscommitted to maximizing each dollar raised, directingan outstanding 93 percent of all funds raised toward itsinnovative research portfolio and related programming.

We have been and always will be a leader in fiscal responsibility. This year, ourexceptional financial management resulted in us reaching several importantmilestones, including:

$115 million raised to date to support cutting-edge multiple myeloma research and drug development

$14 million invested in our research portfolio’s high-priority research programs

A 4-star rating from Charity Navigator for the sixth consecutive year, a ranking that places us among the top two percent of all charities

You can be certain that we make the most of your donation and that your dollarsdo make a difference.

Thank you for support and for your belief in our mission.

Scott SantarellaCOO and Executive Director

Scott SantarellaCOO and Executive Director

4

As a good steward of your donation, the Multiple Myeloma Research Foundation (MMRF) directs anoutstanding 93 percent of contributions toward research and related programming. The MMRF hasconsistently earned top rankings from the nation’s leading charity evaluators for its fiscal responsibility.

An A+ from the American Institute of Philanthropy

A 4-star rating from Charity Navigator

“Best in America” Seal of Excellence from the Independent Charities of America

Complies with the Better Business Bureau’s (BBB) Wise Giving Alliance Standards forCharity Accountability

Approval from the National Cancer Institute (NCI) for our research grants program

The MMRF is the world’s only organization to have received these exceptional accreditations.

2008 Allocation ofMMRF Funds

4% Fundraising

3% Administrative Costs

93% Research Awards and Related Programming

ExceptionalFinancial Management


Accelerating the Delivery of New Treatments

6

The Multiple Myeloma Research Foundation (MMRF) makes the most of your investment bysupporting one of the world’s most strategic and aggressive research and drug developmentportfolios. Our innovative portfolio is comprised of cutting-edge research programs in three paths —basic science, validation, and clinical trials — that represent our long-, mid-, and short-term strategyto deliver to patients the next generation of treatments. With a pay-line averaging 25 percentcompared with the National Cancer Institute’s pay-line of less than 15 percent, we make surethat no high-priority research program goes unfunded.

In 2008, the MMRF directed nearly $14 million toward its innovative research portfolio.

Basic ScienceAccelerating Personalized Medicine

Through our basic science research programs, researchers are learning more about the genes, proteins,and molecular pathways that play a role in the onset and progression of multiple myeloma and areusing that information to better understand which patients will benefit from which treatments.

Multiple Myeloma Genomics Initiative

In 2008, the Multiple Myeloma Genomics Initiative, a comprehensive genome-mapping programconducted in partnership with the Translational Genomics Research Institute (TGen) and theEli and Edythe L. Broad Institute, completed comprehensive analyses of 200 patient tissuesamples. These analyses are helping to identify potential new therapeutic targets for the disease andposition the Initiative to be the first to complete whole genome sequencing in 200 patients.Findings from the Multiple Myeloma Genomics Initiative were presented in oral presentations atthe American Society of Hematology’s (ASH) 50th Annual Meeting and Exposition, and at theAmerican Association of Cancer Research (AACR).

“The Multiple Myeloma Genomics Initiative is critical to

advance personalized medicine in myeloma — helping

us to better understand how to match the right patient

to the right drug at the right time.”

– Todd Golub, MD, Broad Institute of MIT and Harvard

“It gives me tremendous

h o p e t o k n o w t h a t

the MMRF i s work ing

urgently to make sure

new treatments are there

for me when I relapse.”

– Carol Goldschein,

8-Year Multiple

Myeloma Survivor

Multiple Myeloma Proteomics Initiative

The MMRF in 2008 launched the Multiple Myeloma ProteomicsInitiative with the award of a collaborative grant to the University ofArkansas for Medical Sciences, Indiana University, and the Universityof Michigan. This novel program brings together world-renownedproteomics experts with experts in the clinical and biological aspectsof multiple myeloma to identify new biomarkers for the disease.

Multiple Myeloma Cancer Stem Cell Initiative

In 2008, the MMRF and the Leukemia & Lymphoma Societypartnered to award grants to William Matsui, MD, Johns HopkinsUniversity, and Irving Weissman, MD, Stanford University, to studythe multiple myeloma cancer stem cell. These grants, developed inresponse to proceedings from the 2008 MMRF Myeloma CancerStem Cell Research Roundtable, will advance our understandingof drug resistance and relapse in patients with multiple myelomaand potentially lead to the development of targeted therapies thateffectively treat the disease.

MMRF Fellows Awards

Supports researchers with less than five years experience andworking under the supervision of a research sponsor.


Abdel Kareem Azab, PhDDana-Farber Cancer Institute

Tsui-Fen Chou, PhDCalifornia Institute of Technology

Alex Klimowicz, PhDUniversity of Calgary

Eva Martinez, PhDNorthwestern University

Rao Prabhala, PhDBoston VA Research Institute

Wei Xiong, PhDUniversity of Utah

Eyal Zcharia, PhDHadassah Medical Organization

“The MMRF Biotech Investment Award bridges a critical funding gap

that will support the clinical development in myeloma of our promising

novel compound, AT7519, a proprietary CDK inhibitor.”

– Harren Jhoti, PhD, CEO, Astex Therapeutics

8

Accelerating the Delivery of New TreatmentsValidationSpeeding the Next Generation of Treatments

The MMRF supports research aimed at the identification and prioritization of compounds andcombination approaches with the most potential in treating myeloma.

Validation of Novel Combinations and Novel Compounds Awards

Dharminder Chauhan, MDDana-Farber Cancer Institute

Simon Joel, PhDBarts and the LondonSchool of Medicine

Donald Kufe, MDDana-Farber Cancer Institute

Terry Landowski, PhDUniversity of Arizona

Hsiou-Chi Liou, PhDWeill Cornell MedicalCollege

Noopur Raje, MDMassachusetts GeneralHospital

Wim Vanden Berghe, PhDUniversity of Ghent

MMRF Senior Research Awards

Innovative grants supporting researchers with more than f ive years experience inblood cancer research.

David Avigan, MDBeth Israel DeaconessMedical Center

Ralf Bargou, MDUniversity of Wurzburg

Ruben Carrasco, MDDana-Farber CancerInstitute, Boston, MA

Marta Chesi, PhDMayo Clinic

Alfred Goldberg, PhDHarvard Medical School

Lori Hazlehurst, PhDH. Lee Moffitt CancerCenter

Constantine Mitsiades,MD, PhDDana-Farber Cancer Center

Shigeki Miyamoto, PhDUniversity of Wisconsin

Jetze Tepe, PhDMichigan State University

Qing Yi, MD, PhDM.D. Anderson CancerCenter

Fenghuang Zhan, MD, PhDUniversity of Arkansas forMedical Sciences


Clinical TrialsFast-Tracking Clinical Trials

Committed to bringing patients the next generation of treatments asquickly as possible, the MMRF supports start-up activities and conductof Phase I and Phase II clinical trials compounds and combinationsagainst high-priority myeloma targets.

Biotech Investment Awards

With funding for pre-clinical research and early-stage clinical trialsextremely limited, the MMRF Biotech Investment Awards bridge acritical funding gap so that better, more effective treatments canbe developed more rapidly. The 2008 MMRF Biotech InvestmentAwards were granted to Aileron Therapeutics to support thedevelopment of its Stapled Peptide, and to Astex Therapeutics tosupport the development of its proprietary cyclin-dependentkinase (CDK) inhibitor.

Multiple Myeloma Research Consortium

The Multiple Myeloma Research Consortium (MMRC), incollaboration with its partners in the pharmaceutical and biotechindustries, advanced seven clinical trials of novel compounds andcombination approaches in 2008. Data show that recent clinicaltrials conducted through the MMRC clinical trials network wereopened 30 to 40 percent faster than today’s industry andacademic standard—a significant increase enabling patients toaccess new treatments three months earlier. We attribute theseefficiencies to our strong scientific leadership, standardizedcontracts and processes, and on-site project management.

2008

Phase II Merck Zolinza-Velcade

Phase II Torisel-Velcade

Phase I Elotuzumab-Revlimid-Dex

Phase I Celgene Pomalidomide

Phase I PDL Elotuzumab-Velcade-Dex

Phase I RVDD (upfront)

Phase Ib LBH589-Revlimid-Dex

2007

Phase Ib LBH589-Velcade

Phase I Semafore SF1126

Phase II Proteolix Carfilzomib(relapsed)

Phase II Proteolix Carfilzomib (relapsed/refractory)

Phase I Wyeth Torisel-Velcade

Phase I Ortho Tipifarnib-Velcade

Phase II Novartis LBH589

2005-2006

Phase I NPI-0052

Phase I Keryx Perifosine-Revlimid-Dex

Phase I Novartis TKI258

MMRC CLINICAL TRIALS

“The MMRC streamlines every part of

the clinical trials process so trials can be

up and running much faster and, as a

result, shortens the timeline in which

trials are completed and new treatments

are developed.” – Shaji Kumar, MD, Mayo Clinic

Front row, L to R: Dr. Joan Levy; Dr. Louise Perkins; Dr. Anne Farrell, FDA, Office of Oncology Drug Products;Dr. Ken Anderson, Dana-Farber Cancer Institute; Sandra Wear. Back row, L to R: Dr. Paul Richardson,Dana-Farber Cancer Institute; Anne Quinn Young; Dr. Susan Kelley; Dr. Rick Pazdur, FDA-Office of OncologyDrug Products.

Multiple Myeloma Research Foundation (MMRF) Research Roundtables bring together anextraordinary assembly of researchers, scientists from the biotech and pharmaceutical industries,technology pioneers, and representatives from the U.S. Food and Drug Administration (FDA). Thesedynamic events promote a collaborative approach to advancing multiple myeloma research to ensurethat better, more effective treatments are brought to patients as quickly as possible. In 2008, theMMRF convened three Research Roundtables.

Cancer Stem Cell Research Strategies Applications to Multiple Myeloma

This innovative Research Roundtable brought together cancer stem cell experts with leadingmyeloma researchers to gain a better understanding of the multiple myeloma cancer stemcell. Key learnings from this Roundtable were used to develop the Multiple Myeloma Cancer StemCell Initiative.

Accelerating Drug Development in Multiple Myeloma — A Workshop on Optimizing Development & Registration Strategies and Opportunities & Challenges in the Myeloma Drug Development Process

This exciting, two-day Roundtable brought together representatives from more than 20 biotechcompanies with the FDA to discuss regulatory opportunities to advance compounds in their pipelinethat show potential in treating multiple myeloma. Citing the MMRF and MMRC’s success in workingwith biotech companies, participants developed strategies to facilitate clinical trial development andenrollment and to accelerate IRB approvals. The second day of the event was a smaller meetingwhere participants discussed business solutions the MMRF and MMRC could implement to removebarriers slowing drug development and accelerate the delivery of new treatments to patients.

Championing Collaborations to Advance New Treatments

10


As a patient-focused organization, the Multiple Myeloma Research Foundation (MMRF) knowsfirsthand how important it is that multiple myeloma patients and the providers who care forthem understand multiple myeloma and its treatment options. That is why the multiple myelomacommunity consistently looks to us as the nation’s premier and most trusted source of up-to-dateinformation. All MMRF educational services are available free of charge.

Cutting-Edge Web-Site

In 2008, more than 800,000 daily unique visitors viewed the MMRF’s website, www.themmrf.org.This dynamic site provides visitors with information on everything they need to know aboutmyeloma—from research updates to help finding a clinical trial. The website also hosts webcastsfrom major medical meetings, as well footage from teleconferences with research experts.

MMRF Patient Navigator Program

The MMRF Patient Navigator Program is a highly-personalized service that enables patients to findclinical trials that best match their needs. This important resource can be accessed through theMMRF’s website or by calling a toll-free number: 1-866-603-MMCT.

Educational Symposia and Workshops

In 2008, the MMRF was selected, following a highly competitive process, to sponsor educationalsymposia at several national and international workshops and meetings, including the OncologyNursing Society Annual Congress, the American Society of Hematology’s Annual Meeting andExposition, and the American Society of Clinical Oncology Annual Meeting, where it was the onlyfoundation invited to sponsor.

Newsletters

In 2008, each week, more than 16,000 people received MMRF SmartBrief, a weekly email newsletterhighlighting the latest scientific research and clinical trials, and nearly 65,000 people received eachissue of Myeloma Focus, a print newsletter.

African-American Outreach

In 2008, the MMRF launched an African-American Outreach campaign pilot in Chicago. The campaignbrought the faith-based community and civic leaders together to create a plan to raise awarenessabout multiple myeloma within the African-American community. The MMRF distributed educationalmaterials about multiple myeloma and its effects on the African-American community through thechurch health ministries and community health centers. In the year to come, the MMRF will buildupon this campaign in other major urban cities throughout the country.

Educating the MultipleMyeloma Community

The MMRF hosted numerous successful events in 2008, raising millions of dollars toadvance the MMRF’s innovative research portfolio.

MMRF Chicago Awards DinnerApril 23, 2008Chicago, Ill.

The 7 th annua l Ch i c ago

Awards dinner raised more

than $750,000 and drew more

than 500 guests. Legendary

actress and cancer survivor

Diahann Carro l l prov ided

the keynote address , and

actor and comedienne Bonnie

Hunt served as Mistress of

Ceremonies for the sixth time.

Olympic gold medalist and

two-time cancer survivor Scott

Hamilton, the 2007 recipient

of the Spirit of Hope award,

was also an honored guest.

Vice Chairs & Corporate Chair, with the evening's special guests, from L toR: Brian Feltzin, Robert DeBaun, Lester Knight, Diahann Carroll, Connie L.Lindsey, Bonnie Hunt, and Joe Damico

Jim Moriarty (far R) and friends

Raising Fundsfor Research

12

Deborah Norville, Karen Andrews, Cindy Crawford, Tiki Barber,and Kathy Giusti

MMRF Fall GalaNovember 1, 2008Greenwich, Conn.

More than 900 guests attended the 12th annual MMRF Fall Gala, which

raised more than $1.5 million for myeloma research. The Spirit of Hope

Award was presented to supermodel, actress and spokesperson Cindy

Crawford and former New York Giants player Tiki Barber, now an NBC news

correspondent and analyst for NBC’s “Football Night in America”. Deborah

Norville, host of “Inside Edition” and author of Thank You Power, returned

as Mistress of Ceremonies. Other honored guests included former

Congresswoman and myeloma patient Geraldine Ferraro, Congressman

Christopher Shays, sportscaster Bob Costas, and Melanie Bloom, widow of

NBC news correspondent David Bloom.


Traver and Elizabeth Hutchins

Geraldine Ferraro and Deborah Dunsire

Rebecca Lobo, Chris Russo, Alan Kalter, and Congressman Shays

MMRF Race for Research andMarathon ProgramMMRF 5K Race for Research events raised nearly $1.8 million in 2008.

Races were held in nine cities, with thousands of participants, many of

them myeloma patients and their families, leading the way in the

MMRF’s race toward a cure.

2008 was also the inaugural year of the MMRF Marathon/Half Marathon

program. Sixty-two runners raised nearly $300,000 in races in 10 cities,

most notably the prestigious Boston Marathon, ING New York City

Marathon, and Chicago Marathon.

MMRF Race for Research —Philladelphia youngstersenjoying the beautiful day

Running for My Dad,

Raising Funds for Research

“ B e i n g p a r t o f t h e

t e a m t h a t t r a i n e d

a n d r a i s e d f u n d s

fo r the MMRF was a

priceless experience.”

– Jodi Manby (on rightabove), who ran the Santa Barbara Wine

Country Half Marathon in honor of her father,

a myeloma patient

Raising Fundsfor Research

14

George and Norma Fabian

Kathy Giusti, and Ellie and Barry Samson

MMRF Laugh for LifeMay 20, 2008New York, N.Y.

The 6th annual Laugh for Life event, created by sisters Carol Goldschein, Sue Korn

and Cindi Stern raised more than $550,000 for myeloma research. The sold-out event

was hosted once again by comedian Paul Mercurio and featured comedians Pete

Dominich, Ted Alexandro, Andrew Kennedy, and Dan Naturman. Carol Goldschein,

whose myeloma diagnosis originally inspired Laugh for Life, was honored with

the Spirit of Hope Award. Alan Kalter, announcer for the “Late Show with David

Letterman”, was an honored guests, and Marcia Zisselman and family were

presented with a special award for their outstanding contributions to the event.

MMRF Investors CircleScientific SummitOct. 14-15, 2008Greenwich, Conn.

The 4th annual MMRF Investors Circle Scientific Summit,“Accelerat ing Drug Development: Progress Toward aCure,” brought together academia, industry and high-impactphilanthropic donors in a discussion of current research to helpdonors better understand the research initiatives they aresupporting. Speakers included leading researchers from theDana-Farber Cancer Institute, the Moffitt Cancer Center & ResearchInstitute, Proteolix, Inc., and Keryx Biopharmaceuticals, Inc.


Spirit of Hope Award honoreeCarol Goldschein

CommunicatingOur ModelIn 2008, the Multiple Myeloma Research Foundation (MMRF) received extensive print and broadcastmedia coverage of its important work in breaking down barriers to research and drug development.Major media outlets featured the MMRF’s groundbreaking approach to funding myeloma researchand bringing new treatments to patients.

In its Jan. 28 issue, The New Yorker profiled MMRF Founder andCEO Kathy Giusti in an in-depth article entitled “Buying a cure:What business know-how can do for disease,” which traced the development of the MMRF andhighlighted Kathy’s determination and achievements in promoting collaboration in myelomaresearch and the development of new therapies.

Forbes magazine featured the MMRF in its Sept. 15 issue in thearticle “Patient Power,” which underscored the Foundation’ssuccess in promoting and funding research, achieving a leadership role in the biotech andpharmaceutical industries, and speeding up the drug development and approval process.

The MMRF was also featured in the Sept. 4 issue of Time magazine,which highlighted the Foundation’s model for developing more effectivetreatments in the article “He Won His Battle with Cancer.”

MMRF Founder and CEO Kathy Giusti was one of eight Harvard Business Schoolgraduates profiled in a CNBC special report, “The Money Chase—Inside HarvardBusiness School,” which focused on how Kathy has used her business trainingand acumen to create an innovative research and drug development model.

MMRF Executive Director and Chief Operating Officer Scott Santarella rang the bell to opentrading on the NASDAQ stock exchange on Thursday, December 18, 2008. MMRF staff andfriends attended the bell ringing ceremony, which took place at NASDAQ’s MarketSite andBroadcast Studio in Times Square and was broadcast on channels nationwide.

16

MMRF ExecutiveDirector andCOO ScottSantarella andMMRF staff and supportersat the NASDAQbell ringing ceremony

Maximizing Our ResultsIn 2008, the MMRF was invited to share best practices at several internationalthink tanks and summits, including the Biotechnology Industry Organization (BIO)International Convention, Health Research Alliance (HRA) National Conference, andthe TransMed Partnership Forum.

MMRF Founder and CEO Kathy Giusti was also a keynote speaker at the DrugInformation Association (DIA) Annual Meeting and the American Association of CancerResearch (AACR) Industry 2008 Roundtable, where she delivered a keynote address inpartnership with Lori Kunkel, MD, Chief Medical Officer at Proteolix.


Kathy Giusti with Lori Kunkel, MD, and MargaretFoti, PhD, MD, AACR

18

Financials

The MMRF 2008 Audit reported that the Foundation raised$22.7 million.

*Based on gross revenue


Support and Revenue 2008 2007

Contributions $ 7,001,152 $ 4,319,668Private foundation grants 9,936,269 9,883,022Federal grant support 475,796 465,846In-kind contribution 24,404 13,695

Special eventsSpecial events support 5,264,974 7,874,323Less special events expenses (1,780,555) (1,808,862)

Investment return 32,692 239,915

Total support and revenue 20,954,732 20,987,607

ExpensesProgram

Research 13,815,646 14,156,123Education 1,666,752 2,286,439Awareness 364,599 489,049Other program expenses 1,206,472 1,074,625

Total program expenses 17,053,469 18,006,236

Supporting servicesManagement and general 552,453 526,719Fundraising 1,781,766 839,041

Total supporting services 2,334,219 1,365,760

Total expenses 19,387,688 19,371,996

Change in net assets 1,567,044 1,615,611

Net assets, beginning of year 4,778,467 3,162,856

Net assets, end of year $6,345,511 $4,778,467

Multiple Myeloma Research Foundation, Inc.Statements of Activities (Audited) – Years Ended December 31, 2008 and December 31, 2007

MMRF Board of DirectorsW. Dana LaForge, Chairman

Kenneth C. Anderson, MD

Karen Andrews

Robert J. Beall, PhD

Robert B. DeBaun

Frank Douglas, PhD, MD

Kathy Giusti

Stephen Grand

Eugene Grisanti

Alan L. Heller

Frederick H. Joseph

Anthony K. Kesman

Thomas J. Kipps, MD

Lori Marcus

Gerald McDougall

William S. McKiernan

Mike Mortimer

Charles B. Ortner

Edward Jay Phillips

Stuart Rosow

William Wilson, III

Donna Zaccaro

MMRF Honorary BoardLance Armstrong

Dusty Baker

Tiki Barber

Don Baylor

Diahann Carroll

Bob Costas

Katie Couric

Cindy Crawford

Ann Curry

Geraldine Ferraro

Scott Hamilton

Mariska Hargitay

Bonnie Hunt

Senator Kay Bailey Hutchison

Dan Jansen

Diana Krall

Eric McCormack

Deborah Norville

Keith Olbermann

Sharon Osbourne

General Norman Schwarzkopf

Mel Stottlemyre

Brian Williams

Robert & Lee Woodruff

Paula Zahn

MMRF Leadership Council

Joseph M. Hogan

Lester B. Knight

Philip J. Purcell

Robert Wolf

Leadership

20

Donors

Celgene Corporation

Linda Rodgers Emory

Stephen & Nancy Grand

Marvin Family

Millennium Pharmaceuticals, Inc.

Avinoam & Eti Naor

Edward & Leslye Phillips

Pioneer Fund

Sam & Peggy Johnson

Susan Marvin

Schuett Family Foundation

Amgen

Anonymous

Richard & Vicki Birdoff

BSL Capital Inc.

Centocor Ortho Biotech

Robert & Jane DeBaun

Elizabeth H. Donald

Genentech, Inc.

Mike Windsor — Interpacific

Holdings Inc.

Laszlo N. Tauber Family

Foundation

Frank & Margaret Marvin

Novartis

Leon H. & Cindy Rittenberg, Jr.

Barry & Ellie Samson

Thomas & Gertrude Tibstra

Foundation

Valerie Ann Luff Foundation

Estate of Francis I. Wilks

A. Morris & Ruth W. Williams, Jr.

William & Pat Wilson, III

Ambrose Monell Foundation

Vincent & Jennifer Browning

Timothy Curt

Donaghue Foundation

Eli Lilly & Company, Inc.

George & Norma A. Fabian

Steven & Carol Goldschein

Estate of Linda L. Gunther

Steve & Nancy Kaufman

Keno Graphic Services, Inc.

Kyphon, Inc.

Max Fund, Inc.

John E. & Sarah McGinty

Avis J. Mello

Merck & Co., Inc.

David & Anne Ogilvy

Rocco & Patricia Palmer

Pfizer, Inc.

Proteolix, Inc.

Kenneth & Cynthia

Anderson, MD

Aon Foundation

Atlantic Philanthropies, Inc.

Warren L. & Paula Berliner

Chris Blackwell

Blue Oak Charitable Fund

Marc A. Cohen

Richard Corman

Joe & Pam Damico

Daryl & Jamey Daugherty

Bob & Jane DeBaun

Mark B. Dreyfus

Exelon Corporation

Brian & Allison Feltzin

Mark & Laura Fishman

Paul & Kathy Giusti

Eugene & Gretchen Grisanti

Grosvenor Capital

Management, LP

Ted & Paula Sue Heppner

William Hodges & Paula

Mercer, Jr.

Joseph & Lisa Hogan

Robert Hugin

Ed Johnson

Louise Kepley

Anthony K. & Barbara Kesman

Lester & Becky Knight

Kosan Biosciences, Inc.

Dana & Kathleen LaForge

Bob & Lynn Lunn

James Marcus & Lori Tauber

John Marvin

Lois M. McKeag

McNamara Purcell Foundation

The Mihelcic Family

Northern Trust Corporation

Charles Ortner

Rockville Centre St. Patrick’s

Parade, Inc.

SAC Capital Advisors

Tom Snitzer

Nick & Becky Tiller

Towerbrook Capital Partners, LP

TracyLocke

John Twyman

UBS AG

Paul Ullman & Donna Zaccaro

Dorothy R. Underwood

Robert & Carol Wolf

Valentina V. Wuorinen

Newton & Pam Yaeger

Don E. Ackerman

Adco Electrical Corp

Robin Albert

Woodbury H. & Cynthia A.

Andrews

Anonymous

Dean & Kimberly Assink

Baxter International, Inc.

Bayer HealthCare

Pharmaceuticals

Harvey & Joyce Birdoff

David W. & Alison L. Blood

William Butler

Carlson Family Foundation

Richard A. Carter

Joseph Cassano & Ellen Hooker

Cephalon Oncology

Michael Chiusano

Circle of Service Foundation, Inc.

Thomas Conheeney

Cooper Family Foundation

Robert Costas & Jill Sutton

William E. Covey Memorial

Golf Tournament

Crowell Family Foundation, Inc.

James & Susan Davie

DDB Worldwide

Communications Group, Inc.

Donation Line, LLC

William & Cathleen Ellsworth

Dennis Erdle & Lori Pugh-Erdle

Evert Family Charitable Fund

William & Sharon S. Feather

$10,000 TO $24,999

$25,000 TO $49,999

$50,000 TO $99,999

$100,000 TO $499,000

$500,000 TO $999,000

$1 Million+

The support of our donors has ensured that the progress we have made in multiple myeloma will notlose its momentum. The Multiple Myeloma Research Foundation (MMRF) would like to extend itsheartfelt gratitude to all those who contributed to the MMRF in 2008. The following pages gratefullyacknowledge those generous donors from January 1, 2008 through December 31, 2008*.


DonorsKenneth B. & Ellen Forrest

Fran Friedman

Jay & Victoria Furman

GE Capital

Nanny Gifford — Drueding

Foundation

Morris & Gertrude Furman

Foundation

Glancy Foundation, Inc.

Global Impact

Go Green Self Storage

Goldener Executive Search

Associates

Stanley & Pearl Goodman

Arnold & Roberta Greenberg

Hackberry Endowment Partners

Alan & Abbe Heller

Grant Hutchins

Traver & Elizabeth Hutchins

Web Hutchins

Evelyn Illich

Lorraine J. Illich

Interactive Brokers

Group/Timber Hill, LLC

Henry Jarecki

Fred Joseph & Linn Anderson

Kastory Family Foundation

Katzen International, Inc.

Kirkland & Ellis, LLP

Knight Capital Group, LLC

Valerie Krause

Landmark Companies, LLC

Dale Lang

Steven & Wendy Langman

Christopher M. & Katherine A.

Linneman

Carl & Katherine Locher

Martin & Tristen Mannion

Marion Moore Foundation

Neville & Kitty Martin

McCarty Cancer Foundation

McCormick Tribune Foundation

Jack & Julie McGinley

McGinn, Smith & Co., Inc.

William S. & Betsy McKiernan

MediZine

Paul & Jill Meister

W. Lane Miller

Moneta Group, LLC

Eddie & Irma Muller

William B. O’Connor, Esq.

Paul & Anne-Marie Queally

Family Foundation

PepsiCo

Jeanne Phillips

PricewaterhouseCoopers

Reyes Holding, LLC

Allen & Vicki Samson

Jordan Saper & Ms. Jill

Rittmaster

Leonard A. Sarnat

Say Yes To Education

Foundation

Perry Snyderman

Matthew & Marnie Spiegel

Tribal DDB Worldwide

Ungaretti & Harris

Howard & Mindy S. Unger

Vander Werf Family Foundation

Jerry & Susan Walton

Wapping Community Church

Peter & Deborah Weinberg

Jeffery K. & Mary Wirth

World Wrestling Entertainment

The Yazbak Family

Izzy Zalcberg

Craig & Heidi Albert

Karen Andrews

Anonymous

Etta Atkin

Nina Atkinson

Atiim & Virginia Barber

Alvery A. Bartlett, Jr.

Baxter Credit Union

Baxter Healthcare Corporation

Elisabeth R. Bennett

Melanie Bloom & Dan McNulty

Steve & Joyce Bloom

Michael & Susan M. Blum

Richard Boas

John & Margaret Brewer

Brook and Whittle, Inc.

Michael Brooks

Brookstone Homes, Inc.

Mark Brown

Brown Rudick Berlack Israels, LLP

Wally Buchband

David & Carey Burwick

Robert B. & Andrea Callagy

Canyon Ranch

Cardinal Health

Charlotte & William Hindon

Charity Foundation

Mark J. & Katherine Chelsky

Christopher & Julie Ellen Church

John & Lisa Clark

Constantine L. Clemente

Conventures

Cordis Corporation

Daniel & Lori Crowley

CSX Corporation, Inc. Financial

Services

Cuisinart Resort

De Santis

R. Thomas & Denise Decker

David J. Deutsch

Donahue Foundation

Thomas & Marilyn P. Donnelly

Richard Dvorin

EMD Serono Research

Institute, Inc.

EOS Foundation

Epstein Becker & Green, PC

Estate of E. Charles Uphoff

Rand & Lynne Eyberg

Fenwal, Inc.

Richard & Lori Fernandes

Geraldine Ferraro & John

Zaccaro

Joseph & Frances Ferrone

Doug Fierro

Michael Fisch

Kevin M. & Janice Forde

Four Seasons Resort Costa Rica

at Peninsula Papaga

Mark & Cynthia G. Fuller, III

John M. & Grace Gallaway

GE Commercial Finance

Geotechnical and Environmental

Cons., Inc.

Eugene Gluck

Jeff Goldberg

Malcom & Louise Goodridge

Greyhawk Capital, Inc.

Gutman Family Foundation Trust

Hachette Book Group USA

Cici Halloway

Steven Handwerger & Vera

Thomas

Joshua Harlan

Harrah’s St. Louis Casino

& Hotel

David Helfand

Gerald Hirsch

Hollister, Inc.

George & Diana Holway

Horizon Construction Company

Aura Hulme

Illinois Tool Works, Inc.

Infinity Discovery, Inc.

Intermountain Eye & Laser

Centers, PLLC

James McNaughton Builders, Inc.

Edgar D. & Deborah Jannotta

Johnson & Johnson Family of

Companies

Louise Jones-Takata

John M. Joyce

Keryx Biopharmaceuticals, Inc.

Jinwoo Kim

Kirkland & Ellis Foundation

Knott Family Foundation

Jonathan & Sue Korn

Langan Engineering and

Environmental Services

Jack Laschever

Ed & Rose Leventhal

Connie L. Lindsey & John M.

Blackburn

Marjorie Loeb

Loop Capital Markets

Sam & Gabrielle Lurie

Linda Lynn

Kevin & Sheri Lyons

Marquette Partners

Marsh Family Foundation

Martin Partners, LLC

Marx-Better Foundation, Inc.

Gerald & Jennifer McDougall

Miles for Myeloma

Modell Sporting Goods

Morman Group, LLC

MPI NorthEastern NY Chapter

National Basketball Association

$5,000 TO $9,999

22

Everette Newman

Newsweb Corporation

Deborah Norville & Karl Wellner

NRG Energy, Inc.

Loretta Peavey

Marc Pelath

Per and Astrid Heidenreich

Family Foundation

Gloria Perry

PJ Callahan Foundation, Inc.

Private Bank and Trust Company

Chris Reading

Marc & Rosemary Reisch

Jose & Elizabeth B. Ribeiro

Richard Davoud Donchian

Foundation

Lisa & Jay Ring

Ritchey Family Community

Property

Robert Wood Johnson

Foundation

Adam T. & Amy F. Rochlin

Jim Rushin

Gary Sampere

David & Cindi Samson

Sawdust Investment

Managment, Inc.

Edward & Barbara B Scolnick

Pamela R. Shiells

Rocco & Venus Simonetta

Skadden, Arps, Slate, Meagher

& Flom, LLP

Barbara & Ozzie Smith, Jr.

Jonathon & Laurie Soler

St. Vincent’s Comprehensive

Cancer Center

Steck’s Nursery

John & Charlotte Suhler

Teitelbaum Family Charitable

Remainder Unitrust

Tennenbaum Helpern Syracuse

Hirschfritt

Steven Todd

Nancy Van Leuwen

John L. & Barbara Vogelstein

VS Media, Inc.

Elizabeth Warnock

Warren Area Board of

Realtors, Inc.

Washington University Medical

School

William & Barbara Welke

Frederic White

Wintrust Financial Corporation

Pierre & Debbie Wolf

Charles & Carol Young

Marcia Zisselman

ABC News

Arvind Agarwal

Alsan, Inc.

Alston & Bird, LLP

America II Electronics Corp.

Analog Devices

Peter Anderson & Virginia E.

Marvin

Douglas M. Balog

Basser-Kaufman

Leonard S. & Elizabeth Baum

Sandye Berger

Judith Bernhaut

John & Anne Boehle

Jim & Carolyn Bouchard

Bradford Renaissance Portraits

Mary J. Brenneis

George & Zula Crichton-

Brigham

John J. & Barbara M. Burns, Jr.

Thomas W. & Mary Jean

Buschman

Paul Butler

Timothy Carmack

Cars4Charities

Clayton T. Carter

Paul & Cristine Carter

Douglas E. Cauthen

Chesterman Beach Tofino

Andrew & Elizabeth Crossfield

Dacon Corporation

Denihan Hospitality Group

Design Lighting By Marks

Betty Dickson

Daniel & Nancy Donoghue

Edward & Sandra Meyer

Foundation

Enterprise Rent-A-Car

Foundation

Rae Etherington

Jonathan Fleisig

FlightStar, Inc.

Four Seasons Beverly Hills

Frankford Hospital

Fuscone Family Foundation

George Ganem

Philippe Gauthier

George Backer Family

Foundation, Inc.

Geron Corporation

Robert Gifford

Emerson & Carol Gilbert

Give With Liberty Employee

Donations

GivingExpress Program from

American Express

Arnold L. & Merle Goodman

Graycor Services, LLC

Gwendolyn Halsey-Albertson

Foundation

Dale Haase

David & Audrey M. Hammer

Martin & Callistheni S. Hayes

Kaye Hayley

Lloyd & Cathy Heller

Helmar Foundation

Herschend Family

Entertainment Corp.

Hospira Foundation

Robert & Michelle Hougie

Hughes Network Systems

Human Genome Sciences, Inc.

I Do Foundation

IMS Shared Business Services

Interdecor

Jack and Bessie Fiterman

Foundation

Linda Jacob

Dr. Sundar Jagannath

Jay and Rose Phillips Family

Foundation

Lawrence & Bette M. Kahn

Robert (Kam) & Judith

Kamerschen

Kasey Kahne Foundation

Paul Katz

Stanley & Carol Kay

Robert & Dawn L. Kern

Gloria R. Kindman

Marc Klahr

Ian & Carol Knight

E.A. Kratzman & E.A Kratzman

John & Kennetha L. Krehbiel

Laurens Leffingwell

Kenneth & Lilian Lockman

Mike Lynch

M Milestones of CT, LLC

Dariush Maanavi

Kim Marrkand

Stephen Marshall & Sandy

Samberg

William A. & Bobbie Marvin

Paul & Carol McDermott

McGregor Fund

Gerald L. & Donna M.

McMahon

Vince & Linda McMahon

Stacy Mendler

Merrill Lynch & Co. Foundation

Inc. Matching Gifts

Melissa Ann Meschery

William Miely

Tom Mihelcic

H. Kurt Von Moltke

Morgan Stanley

Jay A. Motula

Bruce & Hilary Murray

Stephen & Kimberly S.

Niggeman

Northern New Jersey Cancer

Associates

Michael O’Halleran

Ted Orenstein

Alan Panzer

PDL BioPharma, Inc.

Laura A. Pepper-Doyle

Lousie Perkins, PhD & Jeff

Glans, PhD

Roland & Adelene Perkins

Plaza Construction Corporation

Charles Polizzi

Alan & Sharon Wolmer Portnoi

Milton & Elinore Povill

Progressive Rail

Charles & Ora Ramat

Resource Management Group

Gene & Tracy Rigo

$2,500 TO $4,999


DonorsMilton & Judith Riseman

River Cats Foundation, Inc.

Roberts & Holland, LLP

David & Debra Robson

Alfred & Eileen Rossi

Victor & Deborah M. Sauerhoff

John Schmuck

Lewis & Barbara Schneider

Schwab Charitable Fund

Scripps

Ted & Jennifer Serentelos

Bob & Andrea Sheehy

Bippy Siegal

Marc Silberberg & Barbara

Julius

SOAR Foundation

Raymond & Julie Soffientini

Solon E. Summerfield

Foundation, Inc.

Susan Spagna Dorfman

Pellegrino & Kathy DeLeo-

Spagnuolo

Sparks Exhibits &

Environments Corp.

Bette F. Stein

Steven Steinman

Jay & Katie Stevens

Stanley & Madonna Manley

Swete

Pamela Tate

The Frederick & Margaret

Weyerhaeuser Foundation

The Mahley Family Foundation

Laura Toby

Tulane University

Ronald Unger

University of Pittsburgh

Sanford & Bernice Waldman

Warner Bros. Records

Douglas Waters & Virginia

Johnston

Steve & Becky Watson

Charles & Phillipa Wendel

Donald & Cynthia Wieneke

Stan Wilemon

Michael Winkler

Paul Witteman & Ellie McGrath

Ira & Shirley Yohalem

Zenner Consulting Group, LLC

Todd Zimmerman

Jeff Zisselman

Arnold & Michele Zousmer

3750 Monroe Avenue Associates

Patricia E. Gaither Adams

Ades Foundation

Dave Aho

Jack S. & Margaret Aiello

Marvin & Heather Albert

Elaine Alexander

Alexandria Animal Hospital

Roberto & Melissa Alvarez

Rebecca Aminoff

Susan Amsterdam

Vidya Sagar Anisingaraju

Anreder & Company, Inc.

Barbara Aranowitz

Josephine Arduni

Arizona Verde Fire Protection

Ark Restaurants Corporate

William & Sarah Armstrong

John & Bonnie Arrix

AST Capital Trust Company

of Delaware

Daniel Auclair

Constance Bagley

David Bainbridge

Miriam Bareket

John Barry

Virginia Bartch

Janet W. Battaile

Bead’t for Mulitple Myeloma

Robert J. Beall, PhD

Jed & Elizabeth B. Becker

Ben Larrabee Photography, LLC

Benchmark Technologies

International Corp.

Benesch, Friedlander, Coplan

& Aronoff, LLP

James Berbee

Reid Berman

Robert L. & Libby Berner

Carla Berryann

Hugh Beryman

Victor & Karen E. Binsacca

BJC Healthcare Corp.

Brian & Heiji Black

Charmaine H. Blatt

Doris Blau

Brandon & Janet Blaylock

Henry Block

Charles Boardman

Arnold Bodmer

Michael & Vickie Bolger

Michael Bolling

BOSE Foundation, Inc.

Kenneth A. & Marianne

Bouldin

Gwen Boyd

Michael Boyd

Alan S. & Elizabeth Breece

Breslow Foundation

Brighton Foundation Trust

Rusi & Renu Brij

Bernie Brillstein

Ernie & Ruthie Brod

Duffy W. Brodsky

Brooks Charitable Fund

Brown and Brown Metro

Buddy Brown

Curtis Brown

Bruno’s Semi Trailers

Suzanne Lunt Bubrosky

Joseph D. & Sarah M. Burke

Ned Burns

John & Colleen Busch

Donald & Sara Bush

Greg & Lora Butler

Robert & Lynn R. Callagy

Leonora A. Callahan

J. Terrence & Sharon E.

Carleton

Gregory A. Carlin

Sandra Carlisle

John K. Castle

CDW Corporation

Centre Partners Management,

LLC

Monica Chandochin

Charles and Ann Johnson

Foundation

Charles Engelhard Foundation

Charles River Laboratories, Inc.

Charter Management Company

Arnold & Nilene Evans Chase

Frank Cheatham

Faris & Christine N. Chesley

Gregory & Robin Chess

Paul Chiusano

David Chizewer

CIBC World Markets Corp.

Ciber

Citi Global Impact Funding

Trust, Inc.

Citigroup Global Impact

Funding Trust

Thomas R. Clark

Mark Claude

James & Virginia D. Cleaver

Robert & Donna Clemmens

CME Chicago Mercantile

Exchange

Coakley Tech

Raymond & Karen G. Cohen

Douglas & Suzanne T. Cole

Richard & Kathy Collins

John Comerford & Teresa Olle

Gregory & Robin Comfort

H.R. & Jean T. Compton

Continuum Health, LLC

Harvey Coopersmith

Richard W. Courts

T. Brad Courts

Coventry Health Care, Inc.

Andrew Jay Cowen

Lee & Marilyn Cox

Stuart Crames

Crist Associates

Donald & Toni Crowley

Douglas Cummins

Joseph & Marcie Cunius

Ken C. & Helen Curtis

William R. Cutter

D’Agostino Landscaping, Inc.

Robert & Sara Dalelio

Richard Darling

Frank Z. Davidson & Carol

Fishberg

Michael & Cara Davidson

Davidson Management

Holding, LLC

Davis Wright Tremaine, LLP

Perry De Valpine

Fred Deandrea

John Debacco

$1,000 TO $2,499

24

John & Gayle W. DeBaun

Anthony Decello

Kent DeLucenay

Robert & Ilene Gerstein

Diamond

Jon & Jeanne Director

Dobbs Tire & Auto Centers

Susan Doherty

Bill Donan

Dorothy G. Bender Foundation

Downers Grove Junior

Womans Club

Keven & Yvette Drews

Kimberly Duchossois

Richard & Bonnie Dudley

Kay DueFrene

Thomas L. Duncan

Tom Duncan

Dawn Duquaine

Timothy & Beth Dwyer

Hugh Eaton

Pete & Mia Edwards

Mark & Sandy Ehlert

Richard F. Eisenberg

Richard & Maribeth Ellsworth

David M. Elzemeyer

Thomas Embrescia

Sandor & Sue Engel

Norm M. & Mari Epstein

Oliver Esman

James P. & Kim Fahey

Ursula Fairbairn

Fairmount Park Commission

Frank Fanning

Jo Anne Fasetti

Donna Feig

Robert H. Feldman

Fiesta Bowl

John & Judith Finley

John G. Finley

Joe & Mary Finley

Finnegan Foundation

Donna L. Finney

First United Bank

Helge & Cathy Fischer

Martin & Aurea Fisher

Max & Cindy Fisher

William & Anne Flanagan

Michael Fleischer

Ninetta Fleming

Jay Flynn

Forest Oil Corporation

Elizabeth Foster

Four Seasons Jackson Hole

Jeffrey & Rosalind J. Freidus

Barry & Stacie Friedman

Alan & Ilene Frost

FSH Communications, LLC

Jesse Furman & Ariela Dubler

L. Patrick Gage

John & Susan S. Gainer

Dennis M. Galgano

Jonathan & Amy Gallen

Joseph & Kathleen Gallichio

Edward J. & Diane Gannon

Gar Advertising, Inc.

David & Barbara Garodnick

Garrett Capital Advisors, LLC

Gary & Bernice Lebbin

Foundation, Inc.

A. George & Lea Allen Gebauer

Carol Geer

Arthur & Norrine T. Geib

Gelber Foundation

Michael & Mary Gellert

Georgica Advisors, LLC

Eric Gerster and Padmini Nunna

Edmond Ghisu

G-III Apparel Group, Ltd.

Kenneth Gladden & Dawn

Lepore

Michele Glassser

Barbara Goldberg

Richard Goldberg

Adam & Alicia Grabow

Martha Graettinger

Peter & Elizabeth Granath

Elizabeth Grayer

Robert Greenberg

Michael & Betsy Greene

Gross & Gross, LLP

Stuart & Joan B. Gross

Bruce Grossman

Robert J. Grossman

Group Voyagers, Inc.

Marshall & Rebecca Grueber

David & Jennifer Baum Gruen

David & Blair Grumman

Richard & Doris Gurtler

Brad Gwinn

Claude Gwinn

Ashraf Habibullah

Bruce Hackmeyer

Philip & Susan G. Hagen, Jr.

Carl E. Hale, Jr.

Halland Companies

Connie Hallblade

Bradley Hamburger

Walter W. H & Eleanor Hamilton

John & Cathleen Hammerschlag

Margaret Happel

Jane Harewood

Harold E. Hirsch Foundation, Inc.

Harris N. A.

Robert L. & Maria Hart

Hawaii Community Foundation

Jeff Hawkins & Janet L. Strauss

W. E. Hays

Charleen C. Hebert

Hecht and Company, PC

Ronald E. Hedlund

Heather Heintzman

Gary Heinze

Heraeus Tenevo, Inc.

Hermann Living Fund

Bernard & Marion Herzberg

Hess Companies

Paul M. & Kathryn Houston

Higbee

Barry & Anne L. Hilton

Alan Hoberman

John & Bonnie Hoegl

Douglas Hoerr

Stephen Holowesko

Holzman Family

Howard & Lois Honigfeld

Daniel & Sarah Hooke

Karen Horan

Howard & Maryam Newman

Family Foundation

HR Impact, Inc.

HSBC Philanthropic Programs

A. H. Huntington, III

Judy Hurley

Husch Blackwell Sanders, LLP

Jack Huston

Doug & Sheila Hyman

Jay Iams & Patricia G. Iams

Stephen N. Ifshin, II

Laurie Imhof

Alice Impraim

Infinity Development Corp.

Shawn Ingall

IT Technology

Dale & Amy Izatt

Cecelia Jacques

Mavis James

Nancy Jarecki

Kenneth D. Jenkins

Timothy & Susan A Jensen

Jersey Development, LLC

Jewels of Ocean

JHL Capital Group, LLC

JLL Partners, Inc.

Ken Jockers

John & Joan D’Addario

Foundation Inc.

Christopher J. & Wendy M.

Johnson

Jeffrey & Danyel Johnson

Judy B. Johnson

Jon and Mindy Gray Foundation

Kevin Jordan

Martin J. Joyce

JSM Marketing, LLC

Alan & Peggy Bell Kalter

David & Marianne Kaplan

Mark Kaplan

Robert & Robin Kaplan

Kaplan Rosenow Family

Foundation

Katten Muchin Rosenman

Foundation, Inc.

Michael & Christine Kauffman

Sue Kavetas

Judy J. Keller

Robert Kemp

J. Michael Kennedy

Kenneth Cole Productions, Inc.

Ryan T. Kenny

Kent Family Charitable

Richard Kessler

King-Casey, Inc.

John & Catherine Kirchner

Jeanine Koch

Kia Swee Koh


DonorsKohlberg & Company

David & Lesly R. Koo

Ken Koopersmith and Linda Rice

Richard & Claire Korn

Harry & Julie Kraemer, Jr.

Jack A. & Linda D. Kraemer

Richard W. & Ellen A. Kramer

Stanley & Shirley Kritzik

Frank & Karen Krohn

Calvin & Debbie Krosch

Len & Barb Kuhr

Sanjeev Kumar

Stuart Kuritsky

Mitchell & Galia Kurman

Joel Kurtzberg

Richard Kuzmar

Michael J. Patricia S. Laas

Dave Lager

James L. & Virginia G.

Lakemeyer

John & Mary Lane

Timothy Lane

Snyder Langston

Laura Ziskin Productions

Marta Jo Lawrence

Lawrence and Frances

Bloomberg Foundation

Bob & Jeanette Leaf

Leahy Family Foundation

Douglas & Louise Leatherdale

Philip & Susan Lebowitz

Harold & Lynn P. Leftwich

Lehman Brothers, Inc.

Daniel & Sandra A. Leib

Jules & Mimi Leibman

Pat Lennon

Leonard Jackson Associates

Dominic Lepore

Michael Lerner

Ruth R. Leventhal

Debra Levin

Jerry & Carol L. Levin

Charles & Lori B. Licht

Ted & Sara Liebowitz

William & Annette Lifford

John Lillard

Linek

Howard & Lonnie Lipson

Brian Little

John B. Lowe, Jr.

LRC Photography

April Lubiani

Gerald M. & Alison Luff, Jr.

Pamela M. Lunny

James J. & Mary F. Lynch, Jr.

Nicholas Lynch

Don MacDonald

Anthony & Evelyn Joyce Macino

Sissy Madden

Joe Madonia

Joel K. Manby

Robert & Elizabeth Mandy

Keri & Shelly Manheim

MannKind Corporation

Marangi Disposal

Marcone Appliance Parts Co.

Bo & Julie Marcus

Marina Shrady Desings

Len Mark

Mitchell & Joan H. Markow

Leonard & Marion Marsh

William Martin & Harriet

Golding

Daniel & Kristine D. Marvin

Paul & Maureen H. Marvin

Sarah Marvin

Brian Mastroberti

Worthington Mayo-Smith

Donny McArdle

Elizabeth McCarthy

Peter McCarthy

McCarty Associates

Dennis McClure

Chuck McDaniel

Michael S. McDonough

William K. McGowan

Tom & Laurie Mcgrath

Catherine Michele McHugh

Rebecca McKinney

Jeremy Mckown

Sean & Tracy McManus

Mark & Michelle McMaster

Michael & Gayle McMurry

Clarence Meadows

Thomas F Meagher, Jr.

Ann C. Means

Merrill Lynch & Co.

Foundation, Inc.

Metropolitan National Bank

Charles Metzger

MH Podell Co.

Midway Maintenance, Inc.

Steve Miely

William D. Miely

Millenium Homes

Lyle & Jerrie Miller

Greg Mills

Gregory & Lesa R. Mills

Martin J. & Mendelle Milston

Donald & Suzy Mings

Minocan Investment, Inc.

Arthur & Margaret M. Minson

Irvin M. & Maria Moldlin

Susan Molineaux

Robert Morefield

Alan Morris

Michael & Laurie Morris

Michael & Linda Morris

Don Morrison

Pamela Morrison

Morton’s Steakhouse

Tom & Joan Moverman

Mark & Lemoy Muller

Storch Munves

Steve & Mary Murdock

Erica Murray

Mary Theresa Murray

Matthew & Carla Murray

Robert & Dorothy Nakea

Izak & Susan Namer

Alfred L Nardini

David & Abigail Nash

Rebecca Nassikas

National Football League

Douglas C. & Linda A. Neilsson

New Canaan Baseball/Softball,

Inc.

New England Rugby Referee

Robert & Erin Noonan

James J. & Colleen A. O’Connor

William & Lisabeth M. Ogden

David & Nancy Remy O’Neill

Leona Oriolo

John & Lisa B. O’Rourke

Michael Orscheln

Daren & Karen R. Orzechowski

Sharon Osbourne

OSI Pharmaceuticals

Rich & Kim OToole

Alexander B. Over

Pacific Fleet Submarine

Memorial Association, Inc.

Alphonse & Patsy S. Palmer

John Patterson

Mark & Barbara Patterson

Roger & Jennifer Pearson

John Peckham

James Pelham

Mark & Stephanie L. Perezous

Nathan & Roz Perlmutter

Steven & Susan Perrins

Kim Petersen

Bruce & Sharon Peterson

Kristi Peterson

Beverly A. Pettit

Michelle Snyderman Platt

Martin Pollack

Jessica Pollner

James R. & Betty Powell

Power Marketing Partners

Piero & Marilyn Chinitz Pozzi

Greg & Lorraine Pritchard

Professional Boiler

Maintenance, Inc.

Proskauer Rose, LLP

John H. & Suzanne B. Prunier

John & Diane Prunotto

Hal Purkey

Christopher Pye

Quality Corn & Turfgrass

Gustav & Claire Raaum

Grace Rapinchuk

Reading Entertainment, LLC

James & Heidi M. Reilly

Marvin M. & Susan Reiss

Richard & Deborah Reiss

Maurice Reissman

Research & Education

Foundation

Revel Seven

Victor & Patricia Warshaw Rich

Scott & Kimberly Richbourg

Michael & Susan Richter

Larry Rick

Rio Mar Beach Resort

Anne Riskin

26

The MMRF is grateful for every donation it receives. However, due to space limitations, this list reflectsdonors who have contributed $1,000 or more.

Sarah Robbins

Robert and Jane Toll Foundation

Mr. John Roberts

Rooms To Go Central Corp.

Michele Rose

Rosenbaum Design Group

Jane L. Rosenthal

Wendy K. Ross

Martin Rostowski

Rota Portrait Studio

Steven & Hallam Roth

Jeff & Jacquie Rothe

Marc Rozman

Safeco Insurance Foundation

Robert Salerno

Paul F. Salvatore

Mike Sanders

Sav a Tree

Savoy Capital, Inc.

Kenneth Sawyer

Bill & Pam Saxelby

Richard & Linda B. Schaps

Pearl Schechter

Scherer Schneider Paulick, LLC

Mark Anthony Schiponi

Berry K. & Sheryl Schwartz

Edward Schwartz

Sheila Schwartzburg

Chris Scott

SDSS Kung Fu of Greenwich

Select Investment Realty

Advisors

Brian T. Seltzer

Semafore Pharmaceuticals, Inc.

Theodore & Sheryl Shaker

Dr. James O. Shaw, Jr.

Thomas & Linda Shortway

David & Jill Shulman

Dick & Nan Shupe

William Shutzer

Eric & Karen Siebert

Russell Siebert

Jeffrey Siegal

Lauri Sussman Siegel

Phillip & Veronica Siegel

Siena Construction Corporation

Edward A. & Kathy M. Silver

Paul & Christine Simmons

Barry & Bonnie Singer

Roger & Linda Sisterman

James A. Skinner

Nigel Skinner

Skyline Hotel, LLC

David & Cathy M. Slack

Kevin Smith

Society of Cosmetic Chemists,

NY Chapter

Soil Mechanics

Michael Sokol

Elizabeth Sandra Sondak

Peter & Marie-Regina Sotos

Jerry Spaugh

George & Claire Speen

Gianni & Clare Spera

Arthur & Constance A. Spiegel

David A. Stafman

James & Carolyn S. Stauner

Jaimie & Esta Stecher

Janet Steiner

Mary Beth Stepanek

Sterling Properties

Susan Stewart

Carl Stickel

Dale R. & Gail A. Stockamp

Michael E. Stone

Mel & Jean Stottlemyre

Bryan & Leslie Street

Angela Strick

Jackie Suarez

Lois Svard

Talbots Charitable Foundation

Tanenbaum-Harbor Co., Inc.

Mark D. Teich

David Teiger

The Capital Group Companies

Charitable Foundation

The Jerold B. Katz Foundation

The John R. Kennedy

Foundation, Inc.

The Mark Kingseed & Joan

Breitenbucher Foundation

The Ritz Carlton New York

Central Park

The Ritz Carlton South Beach

The Spine Group, Inc.

Thomas H. Lee Partners, LP

George E. & Sharon L.

Thompson

Jane Thompson

Thompson, Becker &

Bothwell, LLC

Thomson Inc.

Thrivent Financial For

Lutherans

Thunderbird Junior Golf

Foundation

David & Juliet Tibma

Jill Timmons

Hollis & Dorothy Tinsler

Terrance Tomann

Tory Burch

Kimberly Tragerman

Ulrik & Julia Trampe

Kuan Chang Tseng

Matthew J. & Sheryl K. Turk

Paul Ullman & Donna Zaccaro

U.S. Trust, Bank of America

UCONN Co-Op, Univ. of

Conn. Cooperative Corp.

Unconventional Events

John & Donna M. Underwood

Mark Urich

URS Washington Division

Jim & Joy Utts

Valerie Wilson Travel

Bonnie Valiant

Lee & Kathi Van Boven

David H. Vesole

Richard & Patricia Vesper

Vila Vita

Eric Vincent

Gregory & Maria Schuler-Vogler

George & Lynn Vos

Nancy R. Wadhams

Wagner Family Foundation

Jeffrey & Barbara Walder

Christopher & Terri Walker

Judy Walker

Peter & Theresa Warenski

Michael & Frances Waring

Washington, Pittman &

McKeever, LLC

Button Watkins

Sandra Wear

James Webb

Weed and Duryea

Steven & Carolyn B. Weiby

David J. Weiner

Rita Weissman

Anne C. Welke

Wenner Media, LLC

Westin Embassy Row

WG Trading Company Limited

Partnership

Cheryl Whitaker

Daniel & Elvira B. White

Gregory White

Thomas J. & Lois White

Nancy A. Wilcox

William Donald &

Associates, Inc.

Brian & Jane S. Williams

David & Carolyn Williams

Nicholas & Whitney Williams

Barry & Karen Wolf

John & Rita Wolf

Diane Nelson Wood

Jeffrey & Laxmi Wordham

WP Realty Inc.

Wyndham Sugar Bay Resort

Yassky Properties

Charleeton & Sandra G. Younts

Jeffrey W. Yundt

Dennis Zaslavsky

Zevenbergen Capital

Investments, LLC

George & Marianne Zorich


Multiple Myeloma Research Foundation

383 Main AvenueMerrittView – 5th Floor

Norwalk, CT 06851

Ph: (203) 229-0464Fx: (203) 229-0572

E-mail: [email protected]

Multiple Myeloma Research Foundation MMRF supports research aimed at the identification and...

Documents

Transcript of Multiple Myeloma Research Foundation MMRF supports research aimed at the identification and...